Hypertension Associated with Inhibition of the VEGF Pathway in Oncology Patients - Top-Institutions - MDSpire

Hypertension Associated with Inhibition of the VEGF Pathway in Oncology Patients

By
Nicolas L. Palaskas
Jung Hyun Kim
Silvia Fernanda López Moreno
Bernardo Casso-Chapa
Noah I. Beinart
Nnenne Nnanna
Keila Carolina Ostos Mendoza
Anita Deswal
Syed Wamique Yusuf
Efstratios Koutroumpakis
Jun-ichi Abe
Michael S. Ewer
April 28, 2026
0 min

Frontiers In Cardiovascular Medicine

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

MD Anderson Cancer Center

Houston, TX
Key Differentiators
- Cardio-Oncology
- Oncology
- Cardiology
#2

Dana-Farber Cancer Institute

Boston, MA
Key Differentiators
- Cardio-Oncology
- Oncology
- Cardiology
#3

Brigham and Women's Hospital

Boston, MA
Key Differentiators
- Cardiology
- Cardio-Oncology
#4

Memorial Sloan Kettering Cancer Center

New York, NY
Key Differentiators
- Oncology
- Cardio-Oncology
#5

Cleveland Clinic

Cleveland, OH
Key Differentiators
- Cardiology
- Cardio-Oncology

Original Source(s)

Frontiers In Cardiovascular Medicine

Hypertension Associated with Inhibition of the VEGF Pathway in Oncology Patients

by Nicolas L. Palaskas, Jung Hyun Kim, Silvia Fernanda López Moreno, Bernardo Casso-Chapa, Noah I. Beinart, Nnenne Nnanna, Keila Carolina Ostos Mendoza, Anita Deswal, Syed Wamique Yusuf, Efstratios Koutroumpakis, Jun-ichi Abe, Michael S. Ewer
April 28, 2026

Related Content

Frontiers In Immunology

Mechanisms and biomarkers of immune checkpoint inhibitor-associated myocarditis: from T cell imbalance to multicellular crosstalk

by Jiawang Huang, Xiuli Xu, Yucheng Jin, Liping Qiao, Heng Yu, Wenbo Gao, Caie Li
June 4, 2026

Stat News

Grail’s multi-cancer early detection trial was negative. But as an oncologist, I see more to this story

by Sana Raoof
June 4, 2026

Frontiers In Oncology

Gut decisions based on the liver: prediction of colorectal neoplasia using AI-based liver analysis of routine CT scans